Author: Furong Zeng; Ying Guo; Mingzhu Yin; Xiang Chen; Guangtong Deng
Title: Association of inflammatory markers with the severity of COVID-19 Document date: 2020_4_17
ID: mn3b6nrs_2
Snippet: Accumulating evidence has suggested that inflammatory responses play a critical role in the progression of COVID-19, and several markers have some tracing and detecting accuracy for disease severity and fatality (Mehta et al., 2020 , Stebbing et al., 2020 . Inflammatory markers such as procalcitonin (PCT), serum ferritin, erythrocyte sedimentation rate (ESR), acute phase reactant protein C reactive protein (CRP) and interleukin-6 (IL-6) have been.....
Document: Accumulating evidence has suggested that inflammatory responses play a critical role in the progression of COVID-19, and several markers have some tracing and detecting accuracy for disease severity and fatality (Mehta et al., 2020 , Stebbing et al., 2020 . Inflammatory markers such as procalcitonin (PCT), serum ferritin, erythrocyte sedimentation rate (ESR), acute phase reactant protein C reactive protein (CRP) and interleukin-6 (IL-6) have been reported to be significantly associated with the high-risks of the development of severe COVID-19 (Cheng et al., 2020 , Gao et al., 2020 , Qin et al., 2020 . Moreover, increased levels of serum amyloid A(SAA) are shown to be involved in COVID-19 pathogenesis and may serve as a potential biomarker for monitoring disease progression (Cheng et al., 2020 , Xiang et al., 2020 .
Search related documents:
Co phrase search for related documents- acute phase and critical role: 1, 2, 3, 4, 5, 6, 7, 8
- acute phase and disease progression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute phase and disease severity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute phase and erythrocyte sedimentation rate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- acute phase and ESR erythrocyte sedimentation rate: 1, 2, 3, 4, 5, 6, 7
- acute phase and increased level: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- acute phase and inflammatory marker: 1, 2, 3, 4
- acute phase and inflammatory response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute phase and potential biomarker: 1, 2, 3
- critical role and disease progression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- critical role and disease severity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- critical role and erythrocyte sedimentation rate: 1
- critical role and ESR erythrocyte sedimentation rate: 1
- critical role and increased level: 1, 2, 3, 4, 5, 6, 7, 8
- critical role and inflammatory response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- disease progression and erythrocyte sedimentation rate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
- disease progression and ESR erythrocyte sedimentation rate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- disease progression and ESR erythrocyte sedimentation rate serum ferritin: 1, 2, 3
- disease progression and fatality disease severity: 1, 2
Co phrase search for related documents, hyperlinks ordered by date